BestTreat – Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease | BestTreat | Project | Results | H2020 | CORDIS

Livrables

Public dissemination of project results after protection (supported on a dissemination strategy)

The due date of this deliverable is throughout the project

Scientific papers published in high-impact journals with results from WP2-WP5

"All beneficiaries are responsible for the deliverable ""Scientific papers published in high-impact journals with results from WP2-WP5"", and this deliverable is linked to all WPs."

Conference organization on Human Host-Microbiome Symbiotic Interactions - photos and materials

Conference organization on Human Host-Microbiome Symbiotic Interactions – photos and materials

Student public engagement presentations
Awards of doctoral degrees

The due date of this deliverable depends on the duration of the PhD degree in each country and it can be extended to 54 months. All Beneficiaries are Lead Beneficiaries for the deliverable.

Project website
Project social media profiles created and first content published
Development of MOOC on Microbiome Systems Biology - videos and study material

Development of MOOC on Microbiome Systems Biology – videos and study material

BestTreat Data Management Plan

Publications

Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes

Auteurs: Jing Zhang, Yueqiong Ni, Lingling Qian, Qichen Fang, Tingting Zheng, Mingliang Zhang, Qiongmei Gao, Ying Zhang, Jiacheng Ni, Xuhong Hou, Yuqian Bao, Petia Kovatcheva‐Datchary, Aimin Xu, Huating Li, Gianni Panagiotou, Weiping Jia
Publié dans: Advanced Science, 2021, Page(s) 2100536, ISSN 2198-3844
Éditeur: Wiley-VCH
DOI: 10.1002/advs.202100536

Identification and Distribution of Sterols, Bile Acids, and Acylcarnitines by LC–MS/MS in Humans, Mice, and Pigs—A Qualitative Analysis.

Auteurs: Identification and Distribution of Sterols, Bile Acids, and Acylcarnitines by LC–MS/MS in Humans, Mice, and Pigs—A Qualitative Analysis
Publié dans: Metabolites, Numéro 12(1), 2022, Page(s) 49, ISSN 2218-1989
Éditeur: MDPI
DOI: 10.3390/metabo12010049

Role of microbiota and related metabolites in gastrointestinal tract barrier function in NAFLD

Auteurs: Maria Victoria Fernandez-Cantos, Diego Garcia-Morena, Valeria Iannone, Hani El-Nezami, Marjukka Kolehmainen, Oscar P. Kuipers
Publié dans: Tissue Barriers, 2021, Page(s) 1879719, ISSN 2168-8370
Éditeur: Tissue Barriers
DOI: 10.1080/21688370.2021.1879719

Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool

Auteurs: Babu AF, Csader S, Männistö V, Tauriainen MM, Pentikäinen H, Savonen K, Klåvus A, Koistinen V, Hanhineva K, Schwab U
Publié dans: Sci Rep, Numéro 12(1), 2022, Page(s) 6485, ISSN 2045-2322
Éditeur: Nature Publishing Group
DOI: 10.1038/s41598-022-10481-9

hysical Activity and Dietary Composition Relate to Differences in Gut Microbial Patterns in a Multi-Ethnic Cohort—The HELIUS Study.

Auteurs: Houttu V, Boulund U, Nicolaou M, Holleboom AG, Grefhorst A, Galenkamp H, van den Born B-J, Zwinderman K, Nieuwdorp M.
Publié dans: Metabolies, Numéro 11, 2021, Page(s) 858, ISSN 2218-1989
Éditeur: MDPI
DOI: 10.3390/metabo11120858

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease

Auteurs: Veera Houttu, Ulrika Boulund, Aldo Grefhorst, Maarten R. Soeters, Sara-Joan Pinto-Sietsma, Max Nieuwdorp, Adriaan G. Holleboom
Publié dans: Therapeutic Advances in Gastroenterology, Numéro 13, 2020, Page(s) 175628482094174, ISSN 1756-2848
Éditeur: Therapeutic Advances in Gastroenterology
DOI: 10.1177/1756284820941745

Gut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention

Auteurs: Yan Liu, Yao Wang, Yueqiong Ni, Cynthia K.Y. Cheung, Karen S.L. Lam, Yu Wang, Zhengyuan Xia, Dewei Ye, Jiao Guo, Michael Andrew Tse, Gianni Panagiotou, Aimin Xu
Publié dans: Cell Metabolism, Numéro 31/1, 2020, Page(s) 77-91.e5, ISSN 1550-4131
Éditeur: Cell Press
DOI: 10.1016/j.cmet.2019.11.001

Mining, analyzing, and integrating viral signals from metagenomic data

Auteurs: Tingting Zheng, Jun Li, Yueqiong Ni, Kang Kang, Maria-Anna Misiakou, Lejla Imamovic, Billy K. C. Chow, Anne A. Rode, Peter Bytzer, Morten Sommer, Gianni Panagiotou
Publié dans: Microbiome, Numéro 7/1, 2019, ISSN 2049-2618
Éditeur: Springer Nature
DOI: 10.1186/s40168-019-0657-y

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Auteurs: Houttu Veera, Csader Susanne, Nieuwdorp Max, Holleboom Adriaan G., Schwab Ursula
Publié dans: Frontiers in Nutrition, 2021, ISSN 2296-861X
Éditeur: Frontiers
DOI: 10.3389/fnut.2021.716783

Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis

Auteurs: Ambrin Farizah Babu, Susanne Csader, Johnson Lok, Carlos Gómez-Gallego, Kati Hanhineva, Hani El-Nezami, Ursula Schwab
Publié dans: Nutrients, Numéro 13/9, 2021, Page(s) 3135, ISSN 2072-6643
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/nu13093135

Recherche de données OpenAIRE...

BestTreat – Building a Gut Microbiome Engineering Toolbox for In-Situ Therapeutic Treatments for Non-alcoholic Fatty Liver Disease

Livrables

Publications

Partager cette page

Télécharger